Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 CAD | -4.52% | -9.20% | -55.82% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.82% | 18.49M | |
+64.37% | 62.59B | |
-2.03% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.47% | 26.21B | |
-22.05% | 19.09B | |
+3.78% | 13.08B | |
+25.54% | 12.26B | |
+27.17% | 12.05B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Presenting Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib